NCT05738408 Remote Smoking Cessation in Hospitalized Cardiac Patients
| NCT ID | NCT05738408 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Vermont Medical Center |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2022-08-12 |
| Primary Completion | 2025-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2022-08-12 with a primary completion date of 2025-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators are proposing to examine new strategies for helping patients hospitalized for an acute coronary event adhere to recommendations to quit smoking. The investigators are interested to see whether offering financial incentives for smoking cessation, combined with medications to ameliorate withdrawal, can significantly reduce smoking in a population for which continued smoking has disproportionately negative health effects. The proposed trial can provide significant knowledge for promoting adherence to smoking cessation guidelines in patients with cardiac disease
Eligibility Criteria
Inclusion Criteria: Patients will be recruited if they: 1. Hospitalization for an acute coronary event which includes myocardial infarction or coronary revascularization (percutaneous intervention or coronary artery bypass) 2. live within 30 miles of UVMMC and are \>18 years of age 3. Current cigarette smoker (defined as reporting any use of cigarettes in the week before admission and \>5 cigarette/day on average over the past 3 months) Exclusion Criteria: Patients will be excluded if they have: 1. severe dementia/Alzheimer's disease 2. an active malignancy, excluding non-melanoma skin cancer or low-grade prostate cancer under active surveillance 3. exercise limiting vascular or neuromuscular disease 4. Non-English Speaking 5. No reliable smart-phone 6. Current, regular use of smokeless tobacco or other form of non-combusted tobacco
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05738408 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05738408 currently recruiting?
Yes, NCT05738408 is actively recruiting participants. Contact the research team at sherrie.khadanga@uvmhealth.org for enrollment information.
Where is the NCT05738408 trial being conducted?
This trial is being conducted at Burlington, United States.
Who is sponsoring the NCT05738408 clinical trial?
NCT05738408 is sponsored by University of Vermont Medical Center. The trial plans to enroll 50 participants.